EDVINCE
Live / Applied — Non-final action mailed (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 30 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79430938
- Mark type
- Stylized text
- Filed
- 30 Jul 2025
Goods and services
- Class 005 — Pharmaceuticals: Preparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical reagents for medical purposes; preparations for analysis for medical purposes, namely, for the treatment of ischemic disorders and diseases, stroke and subarachnoid hemorrhage and delayed cerebral ischemia (DCI)
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments
Owner
- Edvince AB, SE
Prosecution history
- 01 Apr 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 01 Apr 2026 — REFUSAL PROCESSED BY MPU
- 04 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 03 Mar 2026 — NON-FINAL ACTION WRITTEN
- 31 Jan 2026 — ASSIGNED TO EXAMINER
- 30 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 30 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Sept 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 21 Aug 2025 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB